Welcome to our dedicated page for Delivra Health news (Ticker: DHBUF), a resource for investors and traders seeking the latest updates and insights on Delivra Health stock.
About Delivra Health Brands Inc. (DHBUF)
Delivra Health Brands Inc. (TSXV: DHB, OTCQB: DHBUF) is a consumer packaged goods company operating at the intersection of health and wellness. Headquartered in Vancouver, British Columbia, the company is dedicated to helping individuals take control of their health through innovative, alternative wellness solutions. Delivra Health’s portfolio includes two flagship brands—Dream Water® and LivRelief™—which cater to common health challenges such as sleeplessness, chronic pain, and anxiety.
Core Business and Product Offerings
Delivra Health focuses on developing and marketing proprietary, science-backed products that offer natural and effective relief for everyday health issues. Its Dream Water® line includes sleep aids formulated with ingredients like melatonin, GABA, and 5-HTP, designed to support better sleep quality. Meanwhile, LivRelief™ provides topical pain relief solutions powered by natural active ingredients, targeting chronic pain and inflammation. These products are distributed through a combination of retail partnerships, e-commerce platforms, and direct-to-consumer channels, ensuring broad accessibility for customers across North America and beyond.
Market Position and Industry Context
Operating within the growing health and wellness sector, Delivra Health is uniquely positioned to capitalize on increasing consumer demand for non-pharmaceutical alternatives. The company’s focus on addressing specific health challenges allows it to differentiate itself in a competitive market. Its commitment to innovation is evident in its product development, such as the introduction of Dream Water® Immunity Support Sleep Shots, which combine sleep aids with immune-boosting ingredients like Vitamin D and Zinc. By aligning its offerings with evolving consumer preferences, Delivra Health has established itself as a trusted name in the wellness space.
Revenue Model and Growth Strategy
Delivra Health generates revenue through multiple channels, including retail distribution, online sales, and strategic partnerships. Its products are available in major retail outlets, as well as through its own e-commerce platforms, enabling the company to reach a diverse customer base. The company’s growth strategy includes expanding its product lines, enhancing brand visibility through targeted marketing campaigns, and entering new geographic markets. These efforts are supported by a strong management team and a focus on operational efficiency.
Competitive Landscape
Delivra Health operates in a competitive market, facing challenges from other health and wellness brands offering similar solutions. However, the company differentiates itself through its proprietary formulations, focus on specific health issues, and commitment to quality. Its ability to innovate and adapt to consumer needs positions it as a strong contender in the wellness sector.
Key Differentiators
- Proprietary Formulations: Unique blends of natural ingredients tailored to address specific health challenges.
- Broad Accessibility: Products available through retail, e-commerce, and direct-to-consumer channels.
- Commitment to Innovation: Continuous development of new products to meet evolving consumer needs.
Conclusion
Delivra Health Brands Inc. exemplifies a forward-thinking approach to health and wellness, leveraging innovation and science to deliver effective, alternative solutions. With its strong brand portfolio and strategic growth initiatives, the company is well-positioned to meet the needs of a growing market segment seeking natural remedies for common health issues.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) reported its Q2 2025 financial results, showcasing a 34% net revenue growth to $2,754, up $704 from the same quarter last year. The growth was primarily driven by higher sales of Dream Water® in the U.S. and Canada.
Key financial metrics include:
- Gross profit of $1,294 with a 47% margin (down from 54% last year)
- Increased SG&A expenses of $1,544, up 22% year-over-year
- Adjusted EBITDA of $(194) compared to $(84) in the same period last year
The company increased marketing investments and consumer promotional programs across all channels. Six-month results showed total net revenue of $5,917, a 3% increase, while gross profit decreased to $2,891 with a 49% margin. Management remains confident in achieving their commercial and financial objectives for the fiscal year.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced it will release its financial results for Q2 fiscal 2025, covering the three and six months ended December 31, 2024. The company will host a conference call on Thursday, February 27, 2025, at 11:00 a.m. EST to discuss these results.
The conference call will feature a Q&A session led by President and CEO Gord Davey and CFO Jack Tasse. Interested parties can join via toll-free number 1-833-752-2525 (Canada/USA) or +1-647-846-2674 (International). Participants are advised to dial in 10 minutes before the scheduled start time. A replay will be available on the company's investor page following the call.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced a share consolidation effective February 21, 2025. The consolidation will be implemented on a 1-for-10 basis, reducing the outstanding common shares from 312,617,854 to approximately 31,261,785.
The company's name will remain unchanged, with new CUSIP number 24703H201 and ISIN number CA24703H2019. The consolidation will adjust the exercise price and number of shares for existing stock options and warrants accordingly.
Registered shareholders holding physical certificates will receive a letter of transmittal to exchange their certificates, while beneficial shareholders holding shares through brokers won't need to complete this process.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced plans to implement a 10:1 share consolidation, which will reduce the company's outstanding common shares from 312,617,854 to approximately 31,261,785. The consolidation, approved by the board on January 27, 2025, aims to enhance market appeal and facilitate organic growth.
Shareholders' ownership percentages and voting power will remain largely unchanged, with only minor adjustments for fractional shares. The consolidation will also proportionally adjust the exercise prices and number of shares for existing stock options and warrants. The implementation remains subject to TSX Venture Exchange approval, with the effective date to be announced later.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) reported financial results for Q1 fiscal 2025. Net revenue decreased 14% to $3,163,000 from $3,671,000 in the same period last year, primarily due to reduced Dream Water sales. Gross profit margin slightly declined to 51% from 52%. The company maintained positive Adjusted EBITDA of $16,000, down from $683,000 last year. Expenses increased 20% to $1,607,000, driven by higher investments in sales and marketing campaigns. The company reported a net loss of $478,000 compared to a profit of $226,000 in the previous year.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) reported positive financial results for fiscal 2024, ending June 30, 2024. The company, positioned in the health and wellness sector, saw a 26% year-over-year net revenue growth to $12,378, driven by increased sales in the USA and Canada. Gross profit margin improved to 52% from 49% in the previous year. Adjusted EBITDA increased by 68% to $871K compared to fiscal 2023. The company's portfolio, featuring Dream Water® and LivRelief™ brands, focuses on relief from sleeplessness, chronic pain, and anxiety. CEO Gord Davey emphasized the company's consistent improvement over the past four years and anticipated continued revenue and profitability growth for fiscal 2025.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), a leader in consumer packaged goods in the health and wellness sector, has announced its upcoming annual financial results report for the year ending June 30, 2024. The company will host a conference call on Tuesday, October 8, 2024, at 11:00 a.m. (EST) / 8:00 a.m. (PST) to discuss these results.
The conference call will feature Gord Davey, President and CEO, and Jack Tasse, CFO, who will conduct a Q&A session following management's prepared remarks. Interested parties can join the call by dialing 1-844-763-8274 (Canada/USA Toll Free) or +1-647-484-8814 (International Toll). Participants are advised to dial in 10 minutes before the scheduled start time.
A replay of the call will be available on the company's investor page by the end of the business day on October 8, 2024.
Delivra Health Brands (TSXV: DHB, OTCQB: DHBUF), a leader in the health and wellness sector, has announced the grant of 14,000,000 incentive stock options. This resolution, passed by the Board on May 28, 2024, allows directors, officers, and employees to purchase shares at $0.05 each. These options vest annually over three years and have a five-year term. The initiative aims to align the interests of the company's insiders with its long-term performance and growth strategies.
Delivra Health Brands reported a 36% YoY revenue growth, achieving $8,792K in net revenue for the nine months ending March 31, 2024. The quarterly revenue rose by 31% to $3,071K. The company's adjusted EBITDA improved to $845K from $9K YoY. Gross profit for the nine months was $4,566K, a 61% increase, with a gross margin of 52%, up from 44%. However, total expenses increased by 22% to $3,973K due to marketing initiatives. Quarterly gross profit was $1,540K with a 50% margin. Net loss was $702K for the nine months, compared to $178K last year. The loss per share stood at $0.003 basic and $0.002 diluted. Overall, Delivra Health shows strong revenue growth and improved profitability, despite higher expenses.
FAQ
What is the current stock price of Delivra Health (DHBUF)?
What is the market cap of Delivra Health (DHBUF)?
What does Delivra Health Brands Inc. do?
What are Delivra Health’s main products?
How does Delivra Health generate revenue?
What makes Delivra Health unique in the wellness market?
Where are Delivra Health’s products available?
What industries does Delivra Health operate in?
Who are Delivra Health’s target customers?
How does Delivra Health ensure product quality?
